Search research articles
Contact Us
Filters
Showing results (51-60 of 91) with videos related to
Page
of 10
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 4, 2020
Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant Tuberculosis
Johanna Kuhlin, Lina Davies Forsman, Mikael Mansjö, et al.
International Journal of Antimicrobial Agents
|
August 15, 2024
Increased risk of adverse drug reactions by higher linezolid dose per weight in multidrug-resistant tuberculosis
Johanna Kuhlin, Lina Davies Forsman, Aisha Osman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 19, 2018
Minimum Inhibitory Concentrations of Fluoroquinolones and Pyrazinamide Susceptibility Correlate to Clinical Improvement in Multidrug-resistant Tuberculosis Patients: A Nationwide Swedish Cohort Study Over 2 Decades
Lina Davies Forsman, Jerker Jonsson, Charlotta Wagrell, et al.
Antimicrobial Agents and Chemotherapy
|
April 25, 2023
Population Pharmacokinetics and Dose Evaluation of Cycloserine among Patients with Multidrug-Resistant Tuberculosis under Standardized Treatment Regimens
Yue Zhu, Limei Zhu, Lina Davies Forsman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 15, 2026
Future Prospects for Using Clinical Phenotypes in Tuberculosis Precision Medicine-An Approach for Clinical Management
Katarina Niward, Clara Braian, Gustav Svärdhagen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
May 1, 2020
Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China
Wenpei Shi, Lina Davies Forsman, Yi Hu, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 25, 2021
Emergence of additional drug resistance during treatment of multidrug-resistant tuberculosis in China: a prospective cohort study
Yi Hu, Xubin Zheng, Lina Davies Forsman, et al.
ERJ Open Research
|
June 24, 2025
Protein profiling in intensive care unit-treated COVID-19 patients identifies biomarkers of residual lung abnormalities
Dimitrios Kalafatis, Mikael Björnson, Barbora Svobodová, et al.
Pharmaceutics
|
January 26, 2024
Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis
Shulan Dong, Ge Shao, Lina Davies Forsman, et al.
BMJ Open
|
October 3, 2023
Correlation of drug exposure and bacterial susceptibility with treatment response for <i>Mycobacterium avium complex</i> lung disease: protocol for a prospective observational cohort study
Xubin Zheng, Li Wang, Lina Davies Forsman, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 91) with videos related to
Sort By:
Page
of 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 4, 2020
Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant Tuberculosis
Johanna Kuhlin, Lina Davies Forsman, Mikael Mansjö, et al.
International Journal of Antimicrobial Agents
|
August 15, 2024
Increased risk of adverse drug reactions by higher linezolid dose per weight in multidrug-resistant tuberculosis
Johanna Kuhlin, Lina Davies Forsman, Aisha Osman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 19, 2018
Minimum Inhibitory Concentrations of Fluoroquinolones and Pyrazinamide Susceptibility Correlate to Clinical Improvement in Multidrug-resistant Tuberculosis Patients: A Nationwide Swedish Cohort Study Over 2 Decades
Lina Davies Forsman, Jerker Jonsson, Charlotta Wagrell, et al.
Antimicrobial Agents and Chemotherapy
|
April 25, 2023
Population Pharmacokinetics and Dose Evaluation of Cycloserine among Patients with Multidrug-Resistant Tuberculosis under Standardized Treatment Regimens
Yue Zhu, Limei Zhu, Lina Davies Forsman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 15, 2026
Future Prospects for Using Clinical Phenotypes in Tuberculosis Precision Medicine-An Approach for Clinical Management
Katarina Niward, Clara Braian, Gustav Svärdhagen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
May 1, 2020
Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China
Wenpei Shi, Lina Davies Forsman, Yi Hu, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 25, 2021
Emergence of additional drug resistance during treatment of multidrug-resistant tuberculosis in China: a prospective cohort study
Yi Hu, Xubin Zheng, Lina Davies Forsman, et al.
ERJ Open Research
|
June 24, 2025
Protein profiling in intensive care unit-treated COVID-19 patients identifies biomarkers of residual lung abnormalities
Dimitrios Kalafatis, Mikael Björnson, Barbora Svobodová, et al.
Pharmaceutics
|
January 26, 2024
Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis
Shulan Dong, Ge Shao, Lina Davies Forsman, et al.
BMJ Open
|
October 3, 2023
Correlation of drug exposure and bacterial susceptibility with treatment response for <i>Mycobacterium avium complex</i> lung disease: protocol for a prospective observational cohort study
Xubin Zheng, Li Wang, Lina Davies Forsman, et al.
Page
of 10